211 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ALXN Alexion Pharmaceuticals, Inc. $117.77 $26.25B N/A
Article Searches
Alexion's sBLA for Ultomiris Gets Priority Review From FDA http://www.zacks.com/stock/news/432881/alexions-sbla-for-ultomiris-gets-priority-review-from-fda?cid=CS-ZC-FT-432881 Jun 21, 2019 - The FDA accepts Alexion's (ALXN) sBLA for Ultomiris under priority review for treating atypical hemolytic uremic syndrome to inhibit complement-mediated thrombotic microangiopathy. Shares increase.
3 Big Biotechs Hold Growth Potential in Second Half of 2019 http://www.zacks.com/stock/news/432820/3-big-biotechs-hold-growth-potential-in-second-half-of-2019?cid=CS-ZC-FT-432820 Jun 21, 2019 - We highlight a few leading players from the biotech sector, having surpassed the same so far in 2019 and are likely to put up a good show during the second half of 2019 as well.
Alexion's (ALXN) Ultomiris Gets Approval in Japan for PNH http://www.zacks.com/stock/news/431825/alexions-alxn-ultomiris-gets-approval-in-japan-for-pnh?cid=CS-ZC-FT-431825 Jun 19, 2019 - Alexion (ALXN) receives approval in Japan for its long-acting C5 complement inhibitor, Ultomiris, for the PHN indication.
Biotech Stock Roundup: Amgen Gets FDA Nod for Kanjinti, Regeneron Presents Data http://www.zacks.com/stock/news/431676/biotech-stock-roundup-amgen-gets-fda-nod-for-kanjinti-regeneron-presents-data?cid=CS-ZC-FT-431676 Jun 19, 2019 - Key highlights of the past week include regulatory approvals, collaborations and pipeline updates.
3 Cheap Drug Stocks You Can Buy Right Now https://www.fool.com/investing/2019/06/16/3-cheap-drug-stocks-you-can-buy-right-now.aspx?source=iedfolrf0000001 Jun 16, 2019 - Not all stocks are expensive. These drug stocks look like bargains.
3 Drug Stocks That Could Win From Key FDA Approvals in June https://www.fool.com/investing/2019/06/04/3-drug-stocks-that-could-win-from-key-fda-approval.aspx?source=iedfolrf0000001 Jun 04, 2019 - Two hope to pick up additional indications for existing blockbuster drugs, while another could score a big victory for a new drug.
3 Big Biotech Stocks That Warren Buffett Might Like https://www.fool.com/investing/2019/05/26/3-big-biotech-stocks-warren-buffett-might-like.aspx?source=iedfolrf0000001 May 26, 2019 - There's at least one thing about these biotechs that the Oracle of Omaha should find especially appealing.
3 Top Biotech Stocks to Buy Right Now https://www.fool.com/investing/2019/05/23/3-top-biotech-stocks-to-buy-right-now.aspx?source=iedfolrf0000001 May 23, 2019 - These three biotech stocks should turn out to be outstanding long-term growth vehicles.
3 Reasons Growth Investors Will Love Alexion (ALXN) http://www.zacks.com/stock/news/416683/3-reasons-growth-investors-will-love-alexion-alxn?cid=CS-ZC-FT-416683 May 20, 2019 - Alexion (ALXN) could produce exceptional returns because of its solid growth attributes.
Top 5 New Drug Launches of 2019 -- and the Biotech Stocks That Could Win Big https://www.fool.com/investing/2019/05/19/top-5-new-drug-launches-of-2019-and-the-biotech-st.aspx?source=iedfolrf0000001 May 19, 2019 - These drugs and the biotechs that make them could be on the way to tremendous success in the near future.

Pages: 123456...22

Page 1>